3.2 Biotin and Protein Blocking

ABC and LSAB detection reagents hunt biotin. Polymer and multimer reagents hunt immunoglobulin. Protein blocks hunt sticky, charged, or Fc-receptor surfaces. Mixing those jobs is the usual source of wasted steps—or of dirty liver, kidney, and brain slides.

This section starts from the chemistry used in clinical IHC. Biotin is vitamin B7, covalently bound in mitochondrial carboxylases. Avidin and streptavidin bind biotin with extremely high affinity. If the detection cocktail contains avidin (or streptavidin) and biotinylated HRP, hepatocyte mitochondria are a chromogen target even when the primary antibody is omitted. Biotin-free polymer never offers that binding pair, so the same hepatocyte biotin is invisible. Protein block is a different problem: hydrophobic binding and Fc receptors that capture primary or secondary immunoglobulin.

Endogenous biotin: liver, kidney, and brain

Tissues rich in biotinylated carboxylases include liver hepatocytes, renal tubular epithelium, and some neurons and neuropil. Steroidogenic cells, adipose tissue, and some carcinomas can show the same granular cytoplasmic pattern. The stain is often coarse granular cytoplasmic, mitochondrial in distribution, and present on the negative reagent control when ABC or LSAB is used.

Heat retrieval can expose more biotin. A liver that looked clean with ABC before HIER can turn granular after high-pH retrieval. That is unmasking of biotin, not a new antibody clone problem. Brain is an under-recognized trap: neuronal biotin produces cytoplasmic chromogen that mimics oncocytic or neuroendocrine granularity if the reader does not check the detection chemistry and the omit-primary control.

FFPE does not remove biotin the way it reduces alkaline phosphatase. Formalin cross-links proteins but leaves the biotin prosthetic group available, and retrieval can make it more accessible. Frozen liver and kidney are equally biotin-rich and still need an avidin-biotin block if ABC/LSAB is used.

Avidin-biotin block sequence

The block has two reagents and a fixed order:

1. Unlabeled avidin (or streptavidin) first. It occupies tissue biotin. If you skip this and add free biotin first, free biotin has nothing to bind on the tissue; endogenous biotin is unchanged.
2. Free biotin second. Avidin is tetravalent. After step 1, leftover biotin-binding sites on tissue-bound avidin would capture the biotinylated secondary or the ABC complex. Excess free biotin fills those sites.
3. Rinse, then proceed with primary (or with biotinylated secondary, depending on the kit's insertion point). The detection ABC/LSAB reagents now see neither tissue biotin nor uncapped avidin.

Reverse order fails. Using protein block (casein, BSA, serum) in place of avidin-biotin block also fails: protein does not occupy biotin. Hydrogen peroxide does not occupy biotin either; a peroxide-clean liver can still be biotin-dirty on ABC.

Streptavidin has lower nonspecific lectin-like binding than egg avidin (avidin is glycosylated and strongly basic). Many kits use streptavidin for both the block and the detection. The sequence logic does not change.

Why polymer systems skip biotin block

From first principles used in clinical IHC:

• ABC: primary antibody → biotinylated secondary → preformed avidin-biotin-HRP lattice (or streptavidin-HRP in LSAB). Every biotin in the tissue is a legitimate ligand for that lattice.
• Polymer/multimer: primary antibody → secondary antibodies or Fab fragments displayed on a backbone that already carries many HRP or AP molecules. There is no biotinylated reagent and no avidin. Endogenous biotin has no partner.

A biotin block on a biotin-free polymer run is wasted time. It does not fix red-cell DAB (that is peroxide), and it does not fix Fc-receptor binding (that is protein or serum block, or a better secondary). Conversely, switching a dirty liver ABC assay to polymer often cures hepatocyte granules without any biotin block—because you removed the biotin-binding detection chemistry, not because polymer is a better antibody.

This is why contemporary automated clinical platforms are built biotin-free. ABC remains in the QIHC topic outline because manuals, research kits, older laboratory-developed tests, and some tyramide methods still use biotin. Independent study of those methods still requires the avidin-then-biotin sequence when avidin reagents are on the slide.

Protein block: casein, BSA, and secondary-species serum

Protein block occupies sites that adsorb immunoglobulin nonspecifically:

• Hydrophobic and charged tissue sites (collagen, keratin, necrosis, heavily retrieved FFPE) bind IgG. Casein and BSA compete for those sites.
• Fc receptors on macrophages, B cells, NK cells, and especially frozen lymphoid tissues bind the Fc of primary or secondary antibodies. Normal serum from the species that made the secondary antibody occupies those receptors with immunoglobulin that the secondary will not recognize as target. If the secondary is goat anti-mouse, use normal goat serum—not mouse serum.

Mouse serum as a block on a mouse-primary assay is a classic error: the goat anti-mouse polymer then stains the blocking serum across the whole section. Rabbit serum before a rabbit primary with anti-rabbit polymer is the same mistake.

Typical manual recipes: 1–5% BSA, casein-based commercial blockers, or 5–10% normal secondary-species serum for 10–30 minutes, often with a drain rather than a hard rinse so the protein film stays in place when the primary goes on. Primary diluents that already contain BSA or casein provide a continuous protein background during incubation.

When protein block is redundant on automated kits

Many polymer kits formulate the antibody diluent and the polymer reagent with carrier protein. The automated protocol may list an optional protein block that does not change a well-titered, high-signal assay on routine FFPE. Adding a separate casein step on every run then only adds time.

Protein block is not redundant when:

• Frozen lymphoid tissue with abundant Fc receptors
• Mouse-on-mouse or rabbit-on-rabbit situations, which need dedicated immunoglobulin blocks, not a token BSA dip
• Highly retrieved, necrotic, or collagen-rich specimens with dirty negative controls
• A very dilute primary antibody in a low-protein buffer

Vendor ready-to-use kits that already include blocker in the polymer still require peroxide block for HRP. Protein in the bottle is not hydrogen peroxide, and it is not avidin.

In practice

A kidney ABC-DAB slide shows granular tubular cytoplasm on the omit-primary control. Avidin-then-biotin block cleans it. A polymer-HRP serial section is already clean without that block. Same antigen, different detection ligand.

A frozen lymph node with a mouse anti-CD marker and goat anti-mouse polymer shows macrophage smearing. Goat serum or a dedicated Fc block helps; biotin block does not. If the same pattern appears on FFPE with a protein-containing polymer kit, look at retrieval harshness and primary titer before adding another casein layer.

Never substitute protein block for peroxide on a hemorrhagic spleen, and never substitute avidin-biotin block for polymer conversion when the laboratory has already standardized on biotin-free detection. Choose the block that matches the ligand your detection reagents can actually bind.